Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound

Science
Yusuke SekineDavid Ron

Abstract

The integrated stress response (ISR) modulates messenger RNA translation to regulate the mammalian unfolded protein response (UPR), immunity, and memory formation. A chemical ISR inhibitor, ISRIB, enhances cognitive function and modulates the UPR in vivo. To explore mechanisms involved in ISRIB action, we screened cultured mammalian cells for somatic mutations that reversed its effect on the ISR. Clustered missense mutations were found at the amino-terminal portion of the delta subunit of guanine nucleotide exchange factor (GEF) eIF2B. When reintroduced by CRISPR-Cas9 gene editing of wild-type cells, these mutations reversed both ISRIB-mediated inhibition of the ISR and its stimulatory effect on eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro. Thus, ISRIB targets an interaction between eIF2 and eIF2B that lies at the core of the ISR.

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C de Haro, S Ochoa
Jan 1, 1989·The American Journal of Physiology·S R KimballL S Jefferson
Sep 7, 2002·Molecular and Cellular Biology·Peichuan ZhangDouglas R Cavener
Mar 24, 2009·Nature Methods·Enrico K SchmidtPhilippe Pierre
May 16, 2012·Advances in Nutrition·Thomas D Baird, Ronald C Wek
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Feb 18, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Noel C WorthamChristopher G Proud
May 9, 2014·Biochemistry·Andrew M BogoradAssen Marintchev
May 16, 2014·Biotechnology and Bioengineering·Carlotta RondaHelene Faustrup Kildegaard
May 24, 2014·Nature Communications·Yuliya GordiyenkoCarol V Robinson
Jul 1, 2014·Nature Neuroscience·Gonzalo Viana Di PriscoMauro Costa-Mattioli

❮ Previous
Next ❯

Citations

Jul 15, 2015·Expert Opinion on Therapeutic Targets·Alexis RivasClaudio Hetz
Feb 24, 2016·Nature·Kazuhiro KashiwagiShigeyuki Yokoyama
Dec 31, 2015·Proceedings of the National Academy of Sciences of the United States of America·Aude De GassartFabio Martinon
May 30, 2015·Science·Alan G Hinnebusch
Mar 30, 2016·Brain Research·Oliver J Freeman, Giovanna R Mallucci
Jul 27, 2015·Acta Neuropathologica·Wiep Scheper, Jeroen J M Hoozemans
Jul 2, 2016·Science·David BalchinF Ulrich Hartl
Aug 26, 2016·Frontiers in Psychology·Ralf C Buckley
Aug 30, 2016·Journal of Pharmacological Sciences·Toru HosoiKoichiro Ozawa
Sep 15, 2016·The FEBS Journal·Kazuhiro KashiwagiShigeyuki Yokoyama
Jul 28, 2016·Nucleic Acids Research·Martin D JenningsGraham D Pavitt
Sep 21, 2016·Expert Opinion on Therapeutic Patents·Jeffrey M Axten
Dec 8, 2016·Nucleic Acids Research·Dmitry E AndreevIvan N Shatsky
Nov 18, 2017·The FEBS Journal·Yannis Gerakis, Claudio Hetz
Dec 22, 2017·Journal of Virology·Stephanie J ChildAdam P Geballe
Nov 20, 2016·American Journal of Physiology. Cell Physiology·Scott A Oakes
Apr 28, 2018·Journal of Cell Science·Rafael J ArgüelloPhilippe Pierre
Feb 15, 2018·Cold Spring Harbor Perspectives in Biology·Jennifer Chu, Jerry Pelletier
Feb 15, 2018·Cold Spring Harbor Perspectives in Biology·Ronald C Wek
Jul 11, 2018·Wiley Interdisciplinary Reviews. RNA·Graham D Pavitt
Sep 21, 2018·PLoS Pathogens·Cheng FangDavid A Harris
Mar 27, 2019·The Journal of General Virology·Tomoyasu IsobeAkira Nakanishi
Jan 23, 2019·American Journal of Physiology. Endocrinology and Metabolism·Kefan ZhangYu Wu
May 3, 2019·Science·Kazuhiro KashiwagiTakuhiro Ito
Jun 15, 2019·International Journal of Molecular Sciences·Toshiyuki Nakagawa, Kazunori Ohta

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance (ASM)

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.